José Ruiz López
Our investigation deals with:
1) The design and preparation of noble-metal anticancer drugs and antiangiogenic agents based on the benzimidazole pharmacophore and benzylamine, including new fluorescent coordination compounds.
2) The targeted transport of the most active drugs by conjugation to small peptides, other biomolecules or DNA intercalators.
3) The preparation of noble-metal-based drugs loaded on silk-fibroin nanoparticles to improve cell internalization and to overcome resistance mechanisms.
4) Targeting drug delivery using magnetic nanoparticles.
Finally, we are developing new inhibitors of amyloid-b aggregation based on iridium(III) complexes.
Research group members:
Antonio Donaire González, Venancio Rodríguez Hernández, María Dolores Santana Lario
You can contact us at:
7 March 2017: Conchita Gimeno is one of the awardees of the IUPAC 2017 Distinguished Women in Chemistry
20 October 2016: Second MetDrugs meeting
2 February 2016: First MetDrugs meeting
14 october 2015: The Ministry of Economy and Competitiveness of Spain finances the network